We are live on ! Find out more
JG

Jefferies Group Portfolio holdings

AUM $12B
1-Year Est. Return 6.2%
This Fund
S&P 500
This Quarter Est. Return
-0.51%
1 Year Est. Return
-6.2%
3 Year Est. Return
+88.85%
5 Year Est. Return
+123.14%
10 Year Est. Return
AUM
$12B
AUM Growth
-$88.4M
Cap. Flow
+$128M
Cap. Flow %
1.07%
Top 10 Hldgs %
32.99%
Holding
2,099
New
574
Increased
345
Reduced
315
Closed
495

Sector Composition

Rank Sector Weight
1 Healthcare 3.19%
2 Technology 2.99%
3 Consumer Discretionary 2.77%
4 Industrials 2.27%
5 Financials 2.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASO icon
1476
Academy Sports + Outdoors
ASO
$2.89B
-8,600
Closed -$306K
LONA
1477
CALL
LeonaBio Inc
LONA
$69.4M
-9,290
Closed -$283K
LONA
1478
LeonaBio Inc
LONA
$69.4M
-20,126
Closed -$614K
LONA
1479
PUT
LeonaBio Inc
LONA
$69.4M
-18,130
Closed -$553K
ATRA icon
1480
Atara Biotherapeutics
ATRA
$71.2M
-2,800
Closed -$545K
AU icon
1481
AngloGold Ashanti
AU
$40.3B
-60,000
Closed -$855K
AUR icon
1482
Aurora
AUR
$11.7B
-48,937
Closed -$93.5K
AVTR icon
1483
Avantor
AVTR
$7.81B
-27,161
Closed -$845K
AVXL icon
1484
Anavex Life Sciences
AVXL
$222M
-3,403
Closed -$35.9K
AXTA icon
1485
Axalta
AXTA
$7.01B
-9,683
Closed -$214K
BBWI icon
1486
CALL
Bath & Body Works
BBWI
$4.01B
-375,000
Closed -$10.1M
BBWI icon
1487
PUT
Bath & Body Works
BBWI
$4.01B
-276,000
Closed -$7.43M
BCO icon
1488
Brink's
BCO
$5.02B
-5,110
Closed -$310K
BCRX icon
1489
CALL
BioCryst Pharmaceuticals
BCRX
$2.37B
-200,000
Closed -$2.12M
BCRX icon
1490
BioCryst Pharmaceuticals
BCRX
$2.37B
-76,100
Closed -$805K
BCRX icon
1491
PUT
BioCryst Pharmaceuticals
BCRX
$2.37B
-100,000
Closed -$1.06M
BEAM icon
1492
Beam Therapeutics
BEAM
$2.58B
-8,897
Closed -$344K
BEKE icon
1493
KE Holdings
BEKE
$16.8B
-25,000
Closed -$449K
BFH icon
1494
Bread Financial
BFH
$4.21B
-7,235
Closed -$268K
BILL icon
1495
BILL Holdings
BILL
$4.33B
-4,724
Closed -$519K
BIO icon
1496
Bio-Rad Laboratories Class A
BIO
$8.42B
-417
Closed -$206K
BIRD icon
1497
Smartbird Inc
BIRD
$21.7M
-528
Closed -$41.5K
BNY
1498
Bank of New York Mellon
BNY
$108B
-26,911
Closed -$1.12M
BL icon
1499
CALL
BlackLine
BL
$1.69B
-70,000
Closed -$4.66M
BL icon
1500
BlackLine
BL
$1.69B
-20,250
Closed -$1.35M

Similar funds

Jefferies Group's Q3 2022 Portfolio in Review

As of Q3 2022, Jefferies Group held 2,099 positions worth $12B, down 0.73% from $12B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Jefferies Group's Q3 2022 filing shows 574 new, 345 increased, 315 reduced and 495 closed positions. Its largest new stake was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 1,200,777 shares worth $28.6M. The largest sale was Avis, an estimated $248M.

By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, up from 2.3% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jefferies Group's largest Q3 2022 buy was State Street SPDR Bloomberg Short Term High Yield Bond ETF: 1,200,777 shares worth $28.6M.
  • Jefferies Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $73.8M increase.
  • Jefferies Group's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $105M.
  • Jefferies Group fully exited Avis in Q3 2022, selling an estimated $248M.
  • Jefferies Group's ten largest holdings make up 33% of its $12B portfolio in Q3 2022.
  • Jefferies Group opened 574 new positions and closed 495 in Q3 2022.
  • Jefferies Group's portfolio value fell 0.73% quarter-over-quarter to $12B.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.